Shares of Apollo Hospitals Enterprise Ltd surged 7% and hit a 52-week high of Rs 7,483.90 on 7 November after the company announced its quarterly earnings for July-September. 

The company reported a 63% year-on-year (YoY) increase in consolidated net profit to Rs 379 crore compared to Rs 233 crore reported in the same quarter of the previous fiscal year. The increase in net profit resulted in strong performance and volume growth across its hospital business. 

The revenue from operations of the company during the quarter stood at Rs 5,589 crore, marking a 15% YoY increase due to strong performance across all business segments of the company. 

On the operating front, the earnings before interest, taxes, depreciation, and amortisation (EBITDA) grew by 30% YoY to Rs 816 crore. 

Looking at segment wise growth: 

• Healthcare Services revenue grew by 13.81% YoY to Rs 2,920.4 crore. 
• Retail Health & Diagnostics revenue grew by 14.03% YoY to Rs 403.9 crore. 
• Digital Health & Pharmacy distribution revenue increased by 17.31% YoY to Rs 2,282.2 crore. 

Dr Prathap C. Reddy, founder and chairman of Apollo Hospitals Group, expressed pride in their recent partnership with the Government of Tripura to offer free heart surgeries for children, emphasising their commitment to making healthcare accessible, particularly in underserved areas. In addition to expanding access, 

Apollo is pushing forward with advanced medical technologies such as water vapour thermotherapy for prostate treatment and robotic radiosurgery for cancer care. These cutting-edge solutions aim to make procedures less invasive, shorten recovery times, and improve patient outcomes.

At 11:52 am, the shares of Apollo Hospitals were 6.94% higher at Rs 7,452.20 on NSE.

Discover the next big investment! Unicorn Signals’ IPO screener helps you identify promising initial public offerings. Download Unicorn Signals and get ahead of the curve! Sign Up Now & Find Your Next IPO Gem!